Sponsor

Innovative Molecules GmbH

Germany Lipowskystrasse 10, Sendling, 81373 Munich, Germany

About the sponsor

Clinical research focuses on recurrent genital herpes and suppressive treatment strategies, with interest in antiviral control of symptomatic recurrence and long-term disease management.

Suppressive therapy
Recurrent genital herpes
Antiviral efficacy

The sponsor’s work in this area centers on treatment options for patients with ongoing herpes simplex virus infection.

About Specializations

Innovative Molecules GmbH runs clinical trials in conditions such as Genital herpes simplex, among others.

Genital herpes simplex

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Genital herpes simplex

Recruiting

Investigational

Study of IM-250 capsules compared to placebo in patients with recurrent genital herpes

Investigational

Bulgaria

Participants:18–64 years
Substances:(S)-2-(2',5'-DIFLUORO-[1,1'-BIPHENYL]-4-YL)-N-METHYL-N-(4-METHYL-5-(S-METHYLSULFONIMIDOYL)THIAZOL-2-YL)ACETAMIDE
Sponsor:Innovative Molecules GmbH

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →